Histone Deacetylase Inhibitors from Marine Invertebrates

被引:19
|
作者
Luparello, Claudio [1 ]
Mauro, Manuela [1 ]
Arizza, Vincenzo [1 ]
Vazzana, Mirella [1 ]
机构
[1] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, I-90128 Palermo, Italy
来源
BIOLOGY-BASEL | 2020年 / 9卷 / 12期
关键词
histone deacetylase inhibitors; marine invertebrates; anticancer compounds; biomedical applications; Porifera; Cnidaria; Echinodermata; AZUMAMIDES-A-E; PSAMMAPLIN-A; MYTILUS-GALLOPROVINCIALIS; HDAC INHIBITORS; SPONGE; CANCER; APOPTOSIS; GENUS; JAHA; ECOLOGY;
D O I
10.3390/biology9120429
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Histone deacetylases (HDACs) are enzymes that control gene expression and are involved in the onset of serious human pathologies, including cancer; hence, their inhibitors (HDACis) have received increased attention in recent years. It is known that marine invertebrates produce significant amounts of molecules showing active pharmacological properties and an extensive spectrum of biomedical applications. This review is focused on the description of the molecular, biochemical, and, where available, physiological aspects of marine invertebrate-derived compounds that possess HDACi properties, taking into consideration their possible utilization as treatment agents against different pathological states. Histone deacetylases (HDACs) are key components of the epigenetic machinery controlling gene expression. They are involved in chromatin remodeling events via post-translational histone modifications but may also act on nonhistone proteins, influencing many fundamental cellular processes. Due to the key involvement of HDACs in serious human pathologies, including cancer, HDAC inhibitors (HDACis) have received increased attention in recent years. It is known that marine invertebrates produce significant amounts of secondary metabolites showing active pharmacological properties and an extensive spectrum of biomedical applications. The aim of this review is to gather selected studies that report the extraction and identification of marine invertebrate-derived compounds that possess HDACi properties, grouping the producing species according to their taxonomic hierarchy. The molecular, biochemical, and/or physiological aspects, where available, and modes of action of these naturally occurring HDACis will be recapitulated, taking into consideration their possible utilization for the future design of analogs with increased bioavailability and efficacy, less toxicity, and, also, higher isoform selectivity.
引用
收藏
页码:1 / 24
页数:24
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors and demethylating agents: Clinical development of histone deacetylase inhibitors for cancer therapy
    Piekarz, Richard L.
    Sackett, Dan L.
    Bates, Susan E.
    CANCER JOURNAL, 2007, 13 (01): : 30 - 39
  • [32] Effects of histone deacetylase inhibitors on alloresponses
    Hancock, Wayne W.
    LANCET ONCOLOGY, 2014, 15 (01): : 10 - 11
  • [33] Immunomodulatory Effects of Histone Deacetylase Inhibitors
    Licciardi, P. V.
    Ververis, K.
    Tang, M. L.
    El-Osta, A.
    Karagiannis, T. C.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (04) : 640 - 647
  • [34] Histone deacetylase inhibitors in cancer therapy
    Lee, Min-Jung
    Kim, Yeong Sang
    Kummar, Shivaani
    Giaccone, Giuseppe
    Trepel, Jane B.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 639 - 649
  • [35] Design of novel histone deacetylase inhibitors
    Siliphaivanh, Phieng
    Harrington, Paul
    Wittera, David J.
    Ottea, Karin
    Tempest, Paul
    Kattar, Sam
    Kral, Astrid M.
    Fleming, Judith C.
    Deshmukh, Sujal V.
    Harsch, Andreas
    Secrist, Paul J.
    Miller, Thomas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4619 - 4624
  • [36] Dietary agents as histone deacetylase inhibitors
    Myzak, Melinda C.
    Ho, Emily
    Dashwood, Roderick H.
    MOLECULAR CARCINOGENESIS, 2006, 45 (06) : 443 - 446
  • [37] Histone deacetylase inhibitors that target tubulin
    Schemies, Joerg
    Sippl, Wolfgang
    Jung, Manfred
    CANCER LETTERS, 2009, 280 (02) : 222 - 232
  • [38] HDACiDB: a database for histone deacetylase inhibitors
    Murugan, Kasi
    Sangeetha, Shanmugasamy
    Ranjitha, Shanmugasamy
    Vimala, Antony
    Al-Sohaibani, Saleh
    Rameshkumar, Gopal
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2257 - 2264
  • [39] Histone deacetylase inhibitors and cell death
    Zhang, Jing
    Zhong, Qing
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (20) : 3885 - 3901
  • [40] Discovery and development of histone deacetylase inhibitors
    Yoshida, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162